Should adjunctive antipsychotic treatment be continued in remitted patients with depression?
Uchida
Hiroyuki
H
Suzuki
Takefumi
T
Watanabe
Koichiro
K
Kashima
Haruo
H
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008134:Long-Term Care; D008297:Male; D017374:Paroxetine / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D013469:Sulpiride / Q000627:therapeutic use
D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D017374:Paroxetine; D013469:Sulpiride